Latest News
STAT+: Pharmalittle: We’re reading about a Trump Jr. company, a GLP-1 health risk, and much more
A company that has Donald Trump Jr. on its board debuted a new service to help pharmaceutical companies launch direct sales platforms
CDC staff voice fears about agency’s security vulnerabilities in internal calls
“This didn’t come out of nowhere”: What frustrated and scared CDC staffers want after Friday’s shooting.
STAT+: Generative AI tools for doctors consolidate as Doximity acquires Pathway
In STAT's Health Tech newsletter: Doximity acquires Pathway, Omada's first earnings call, and Abridge’s Highmark deal
STAT+: Questions surround a pharma DTC company with ties to Trump Jr.
Plus more biotech news stories of the day, brought to you by The Readout.
STAT+: Boston’s lab building boom has gone bust. What can be done with the empty space?
Nearly 36% of lab space in the Boston area is now empty.
STAT+: Challenges mount for RFK Jr. and his MAHA agenda
Issues are piling up on Kennedy's watch, from responding to the CDC shooting to infighting over an FDA official.
CDC leaders attempt to reassure staff after shooting, but meeting is brief
An all-hands meeting at the CDC to discuss the attack on the agency on Friday was brief and chaotic, staffers say.
STAT+: Prasad returns to the FDA, Attack on the CDC
This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.
STAT+: Insmed’s lung disease drug approved in the U.S.
Insmed has received FDA clearance for the first treatment for a chronic lung disease, opening the biotech up to what could be a multibillion-dollar pr...
STAT+: As AI spreads through health care, is the technology degrading providers’ skills?
A new study suggests that, after having a specialized AI tool taken away, clinicians were less proficient at colonoscopies.
STAT+: Pharmalittle: We’re reading about a Trump Jr. company, a GLP-1 health risk, and much more
CDC staff voice fears about agency’s security vulnerabilities in internal calls
STAT+: Generative AI tools for doctors consolidate as Doximity acquires Pathway
STAT+: Questions surround a pharma DTC company with ties to Trump Jr.
STAT+: Boston’s lab building boom has gone bust. What can be done with the empty space?
STAT+: Challenges mount for RFK Jr. and his MAHA agenda
CDC leaders attempt to reassure staff after shooting, but meeting is brief
STAT+: Prasad returns to the FDA, Attack on the CDC
STAT+: Insmed’s lung disease drug approved in the U.S.
STAT+: As AI spreads through health care, is the technology degrading providers’ skills?
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago